These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25404096)

  • 1. Recommendations for the management of patients with familial hypercholesterolemia.
    Feldman DI; Blaha MJ; Santos RD; Jones SR; Blumenthal RS; Toth PP; Sperling LS; Martin SS
    Curr Atheroscler Rep; 2015 Jan; 17(1):473. PubMed ID: 25404096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of familial hypercholesterolemia instruction in US schools and colleges of medicine, pharmacy, and osteopathic medicine.
    Withycombe B; Winden JC; Hassanyn R; Duell PB; Ito MK
    J Clin Lipidol; 2015; 9(3):281-8. PubMed ID: 26073385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ
    J Clin Lipidol; 2014; 8(2):148-72. PubMed ID: 24636175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia.
    Vella A; Pineda AA; O'Brien T
    Mayo Clin Proc; 2001 Oct; 76(10):1039-46. PubMed ID: 11605688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
    Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ
    Int J Cardiol; 2014 Feb; 171(3):309-25. PubMed ID: 24418289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
    Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document].
    Mata P; Alonso R; Ruiz A; Gonzalez-Juanatey JR; Badimón L; Díaz-Díaz JL; Muñoz MT; Muñiz O; Galve E; Irigoyen L; Fuentes-Jiménez F; Dalmau J; Pérez-Jiménez F
    Semergen; 2015; 41(1):24-33. PubMed ID: 25042971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia.
    Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF
    Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
    McGowan MP
    J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
    Faggiano P; Pirillo A; Griffo R; Ambrosetti M; Pedretti R; Scorcu G; Werren M; Febo O; Malfatto G; Favretto G; Sarullo F; Antonini-Canterin F; Zobbi G; Temporelli P; Catapano AL;
    Int J Cardiol; 2018 Feb; 252():193-198. PubMed ID: 29249427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial hypercholesterolemia in cardiac rehabilitation: a new field of interest].
    Ambrosetti M; Malfatto G; Maria Cremona A; Arca M; Faggiano P
    Monaldi Arch Chest Dis; 2014 Jun; 82(2):87-92. PubMed ID: 25845092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
    Civeira F;
    Atherosclerosis; 2004 Mar; 173(1):55-68. PubMed ID: 15177124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low-density lipoprotein apheresis in familial hypercholesterolemia resistant to intensive medical treatment].
    Arbona C; Martinez-Hervás S; Goterris R; Montoro J; Real JT; Ascaso JF
    Med Clin (Barc); 2013 Mar; 140(5):207-10. PubMed ID: 22571847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of familial hypercholesterolemia in Spain: consensus document].
    Mata P; Alonso R; Ruiz A; Gonzalez-Juanatey JR; Badimón L; Díaz-Díaz JL; Muñoz MT; Muñiz O; Galve E; Irigoyen L; Fuentes-Jiménez F; Dalmau J; Pérez-Jiménez F;
    Aten Primaria; 2015 Jan; 47(1):56-65. PubMed ID: 24704195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.